Publikationen 2012

Bosch JJ:(2012)Immunotherapy of uveal melanoma.Dev Ophthalmol. 2012;49(): 137-49
Krieg S, Ullrich E:(2012)Novel immune modulators used in hematology: impact on NK cells.Front Immunol. 2012;3(): 388
Brunner S, Huber BC, Weinberger T, Vallaster M, Wollenweber T, Gerbitz A, Hacker M, Franz WM:(2012)Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction.J Cell Mol Med. 2012;16(1): 152-9
Gary R, Voelkl S, Palmisano R, Ullrich E, Bosch JJ, Mackensen A:(2012)Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8+ T Cells via Trogocytosis.J Immunol. 2012;188(2): 744-52
Ullrich E, Bosch J, Aigner M, Voelkl S, Kroeger I, Hoffmann P, Kreutz M, Dudziak D, Gerbitz A:(2012)Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany.Cancer Immunol Immunother. 2012;61(3): 433-43
Krause SW, Gerken M, Andreesen R, Hofstädter F, Klinkhammer-Schalke M:(2012)Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry.Ann Hematol. 2012;91(4): 561-70
Röllig C, Brandts C, Shaid S, Hentrich M, Krämer A, Junghanß C, Schleyer E, Müller-Tidow C, Berdel WE, Ritter B, Pflüger KH, Kramer M, Haibach M, Ehninger G, Serve H, Krause SW:(2012)Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemia.Leuk Lymphoma. 2012;53(6): 1062-7
Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R:(2012)HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines.J Immunol. 2012;188(5): 2136-45
Mougiakakos D, Okita R, Ando T, Dürr C, Gadiot J, Ichikawa J, Zeiser R, Blank C, Johansson CC, Kiessling R:(2012)High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis.J Mol Med. 2012;90(8): 935-44
Meinhardt K, Kroeger I, Abendroth A, Müller S, Mackensen A, Ullrich E:(2012)Influence of NK cell magnetic bead isolation methods on phenotype and function of murine NK cells.J Immunol Methods. 2012;378(1-2): 1-10
Schubert I, Kellner C, Stein C, Kügler M, Schwenkert M, Saul D, Stockmeyer B, Berens C, Oduncu FS, Mackensen A, Fey GH:(2012)A recombinant triplebody with specificity for CD19 and HLA-DR mediates ?preferential binding to antigen double-positive cells by dual-targeting.MAbs. 2012;4(1): 45-56
Gerbitz A, Sukumar M, Helm F, Wilke A, Friese C, Fahrenwaldt C, Lehmann FM, Loddenkemper C, Kammertoens T, Mautner J, Schmitt CA, Blankenstein T, Bornkamm GW:(2012)Stromal interferon-? signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice.PLoS ONE. 2012;7(3): e34552
Le Blanc K, Mougiakakos D:(2012)Multipotent mesenchymal stromal cells and the innate immune system.Nat Rev Immunol. 2012;12(5): 383-96
Etschel JK, Hückelhoven AG, Hofmann C, Zitzelsberger K, Maurer K, Bergmann S, Mueller-Schmucker SM, Wittmann J, Spriewald BM, Dörrie J, Schaft N, Harrer T:(2012)HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.J Immunol Methods. 2012;380(1-2): 40-55
Abele-Ohl S, Leis M, Wollin M, Mahmoudian S, Hoffmann J, Müller R, Heim C, Spriewald BM, Weyand M, Stamminger T, Ensminger SM:(2012)Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model.Am J Transplant. 2012;12(7): 1720-9
Jacobs B, Ullrich E:(2012)The Interaction of NK Cells and Dendritic Cells in the Tumor Environment: How to Enforce NK Cell &amp; DC Action Under Immunosuppressive Conditions?Curr Med Chem. 2012;19(12): 1771-9
Reinwald M, Spiess B, Heinz WJ, Vehreschild JJ, Lass-Floerl C, Kiehl M, Schultheis B, Krause SW, Wolf HH, Bertz H, Maschmeyer G, Hofmann WK, Buchheidt D:(2012)Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.Eur J Haematol. 2012;89(2): 120-7
Gottfried E, Kreutz M, Mackensen A:(2012)Tumor metabolism as modulator of immune response and tumor progression.Semin Cancer Biol. 2012;22(4): 335-41
Reinwald M, Hummel M, Kovalevskaya E, Spiess B, Heinz WJ, Vehreschild JJ, Schultheis B, Krause SW, Claus B, Suedhoff T, Schwerdtfeger R, Reuter S, Kiehl MG, Hofmann WK, Buchheidt D:(2012)Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.J Antimicrob Chemother. 2012;67(9): 2260-7
Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L:(2012)Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells.Cancer Res. 2012;72(11): 2757-2767
Mougiakakos D, Machaczka M, Jitschin R, Klimkowska M, Entesarian M, Bryceson YT, Henter JI, Sander B, Le Blanc K:(2012)Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells.Stem Cells Dev. 2012;21(17): 3147-51
Trocmé E, Mougiakakos D, Johansson CC, All-Eriksson C, Economou MA, Larsson O, Seregard S, Kiessling R, Lin Y:(2012)Nuclear HER3 is associated with favorable overall survival in uveal melanoma.Int J Cancer. 2012;130(5): 1120-7
Lehmann FM, Feicht S, Helm F, Maurberger A, Ladinig C, Zimber-Strobl U, Kuhn R, Mautner J, Gerbitz A, Bornkamm GW:(2012)Humanized c-Myc Mouse.PLoS ONE. 2012;7(7): e42021
Lichtenfels R, Mougiakakos D, Johansson CC, Dressler SP, Recktenwald CV, Kiessling R, Seliger B:(2012)Comparative expression profiling of distinct T cell subsets undergoing oxidative stress.PLoS ONE. 2012;7(7): e41345
Kiessling R, Okita R, Mougiakakos D, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kono K:(2012)Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells.Oncoimmunology. 2012;1(7): 1200-1201
Kremer AN, Hoffmann H:(2012)Subtractive hybridization yields a silver resistance determinant unique to nosocomial pathogens in the Enterobacter cloacae complex.J Clin Microbiol. 2012;50(10): 3249-57
Kremer A, Hoffmann H:(2012)Prevalences of the Enterobacter cloacae complex and its phylogenetic derivatives in the nosocomial environment.Eur J Clin Microbiol Infect Dis. 2012;31(11): 2951-5
Zerr P, Distler A, Palumbo-Zerr K, Tomcik M, Vollath S, Dees C, Egberts F, Tinazzi I, Del Galdo F, Distler O, Schett G, Spriewald BM, Distler JH:(2012)Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.Am J Pathol. 2012;181(5): 1672-80
Zerr P, Palumbo-Zerr K, Distler A, Tomcik M, Vollath S, Munoz LE, Beyer C, Dees C, Egberts F, Tinazzi I, Del Galdo F, Distler O, Schett G, Spriewald BM, Distler JH:(2012)Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease.Blood. 2012;120(14): 2909-17
Goldmann K, Ensminger SM, Spriewald BM:(2012)Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance.Clin Vaccine Immunol. 2012;19(11): 1758-64
Hoffmann J, Böhm M, Abele-Ohl S, Ramsperger-Gleixner M, Spriewald BM, Zinser E, Steinkasserer A, Weyand M, Ensminger SM:(2012)Reduction of transplant arteriosclerosis after treatment with mycophenolate mofetil and ganciclovir in a mouse aortic allograft model.Exp Clin Transplant. 2012;10(6): 592-600
Ehlers M, Papewalis C, Stenzel W, Jacobs B, Meyer KL, Deenen R, Willenberg HS, Schinner S, Thiel A, Scherbaum WA, Ullrich E, Zitvogel L, Schott M:(2012)Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice.Endocrinology. 2012;153(9): 4367-79
Hundorfean G, Agaimy A, Chiriac MT, Rösler W, Mackensen A, Siebler J, Neurath MF:(2012)Highlighting Crypt Necrosis by Using Confocal Laser Endomicroscopy for the In Vivo and Real-Time Diagnosis of GI Graft-Versus-Host Disease.J Clin Oncol. 2012;30(35): e368-9
Reddy PN, Sargin B, Choudhary C, Stein S, Grez M, Müller-Tidow C, Berdel WE, Serve H, Brandts CH, Study Alliance Leukemia (SAL) , Schulz-Abelius A, Friedrichsen K, Repp R, Helm G, Kiani A, Krost A, Thiel E, Baldus C, Possinger K, Kühnhardt D, Görner M, Probst S, Pflüger KH, Diekmann C, Mayer J, Protivankova M, Hänel M, Herbst R, Pielken HJ, Hindahl H, Ehninger G, Schaich M, Mackensen A, Krause S, Serve H, Brandts C, Kiehl M, Stein W, Höffkes HG, Ranze O, Schmitz N, Stuhlmann R, Schmidt H, Buhrmann K, Dürk HA, Metzner D, Ho A, Bellos F, Kaiser U, Bartholomäus A, Fauser AA, Basara N, Link H, Mahlmann S, Wolf M, Ritter B, Löffler LM, Kürschner D, Neuhaus T, Hoffmann C, Fetscher S, Schmielau J, Lehnert H, Brüggemann S, Neubauer A, Sohlbach K, Schleyer E, Griesshammer M, Tischler HJ, Lutz L, Hentrich M, Berdel W, Müller-Tidow C, Wilhem M, Schäfer-Eckart K, Jakob A, Dresel I, Gaska T, Niemeyer E, Kozák T, Vydra J, Reichle A, Holler E, Heits F, Meinhardt A, Geer T, Hrusovsky I, Kanzler S, Reinel HH, Heidemann E, Kaesberger J, Aulitzky WE, Leimer L, Clemens MR, Mahlberg R, Frickhofen N, Fuhr HG, Sandmann M, Becker G, Einsele H, Goebeler ME:(2012)SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control.Blood. 2012;120(8): 1691-702
Kremer AN, van der Meijden ED, Honders MW, Goeman JJ, Wiertz EJ, Falkenburg JH, Griffioen M:(2012)Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.Blood. 2012;120(16): 3246-55
Bruns H, Stegelmann F, Fabri M, Döhner K, van Zandbergen G, Wagner M, Skinner M, Modlin RL, Stenger S:(2012)Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages.J Immunol. 2012;189(8): 4069-78
Harre U, Keppeler H, Ipseiz N, Derer A, Poller K, Aigner M, Schett G, Herrmann M, Lauber K:(2012)Moonlighting osteoclasts as undertakers of apoptotic cells.Autoimmunity. 2012;45(8): 612-9
Hauschild A, Kolbl O, Mackensen A, Schadendorf D:(2012)[Foreword].Onkologie. 2012;35 Suppl 2(): 1
Hanfstein B, Müller MC, Hehlmann R, Erben P, Lauseker M, Fabarius A, Schnittger S, Haferlach C, Göhring G, Proetel U, Kolb HJ, Krause SW, Hofmann WK, Schubert J, Einsele H, Dengler J, Hänel M, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Branford S, Hughes TP, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Saußele S, Hochhaus A, SAKK , German CML Study Group:(2012)Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).Leukemia. 2012;26(9): 2096-102

Publikationen 2012

Publikationen 2012

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre